SCD and fatty liver disease: Increased lipogenesis (<i>mRNA Scd1</i>), oxidative stress (decreased SOD activity) and inflammation (<i>mRNA Tnfα) in the liver may contribute to the development of hepatic steatosis and hepatic lipid accumulation.